Skip to main content
Heliyon logoLink to Heliyon
. 2023 Sep 9;9(9):e19944. doi: 10.1016/j.heliyon.2023.e19944

Corrigendum to “Helicobacter pylori infection contributes to the expression of Alzheimer's disease-associated risk factors and neuroinflammation” [Heliyon 9(9) (September 2023) e19607]

Maryam Noori a, Ramina Mahboobi b, Ali Nabavi-Rad a, Shaghayegh Jamshidizadeh a, Farzaneh Fakharian a, Abbas Yadegar a,, Mohammad Reza Zali c
PMCID: PMC10559342  PMID: 37809650

In the original published version of this article, the included Fig. 1 is not correct and does not correspond to the results of the test performed in the study. The correct Fig. 1 presents the details for cell viability determined by MTT assay. The authors have now provided the correct Fig. 1, which can be found below.

Fig. 1.

Fig. 1.

Cell viability was determined using MTT assay for (A) U87MG and (B) 1321N1 cell lines treated with H. pylori (MOI 50 and 100) for 24 h (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001).

The authors apologize for the errors. Both the HTML and PDF versions of the article have been updated to correct the errors.

Declaration of competing interest

The authors declare no conflict of interest.


Articles from Heliyon are provided here courtesy of Elsevier

RESOURCES